Rituximab-associated posterior reversible encephalopathy syndrome

Int J Rheum Dis. 2019 Jan;22(1):160-165. doi: 10.1111/1756-185X.13427. Epub 2018 Nov 5.

Authors

Khader N Mustafa¹, Ula Qasem¹, Nosaiba T Al-Ryalat², Isam K Bsisu³

Affiliations

¹ Division of Rheumatology, Department of Internal Medicine, Jordan University Hospital, University of Jordan, Amman, Jordan.
² Department of Radiology, Jordan University Hospital, University of Jordan, Amman, Jordan.
³ School of Medicine, Jordan University Hospital, University of Jordan, Amman, Jordan.

PMID: 30398015
DOI: 10.1111/1756-185X.13427

No abstract available

Publication types

Case Reports
Letter
Systematic Review

MeSH terms

Adult
Disease Progression
Fatal Outcome
Female
Humans
Immunosuppressive Agents / adverse effects*
Lupus Nephritis / diagnosis
Lupus Nephritis / drug therapy*
Lupus Nephritis / immunology
Magnetic Resonance Imaging
Posterior Leukoencephalopathy Syndrome / chemically induced*
Posterior Leukoencephalopathy Syndrome / diagnostic imaging
Posterior Leukoencephalopathy Syndrome / therapy
Rituximab / adverse effects*
Treatment Outcome

Substances

Immunosuppressive Agents
Rituximab